Assertio Therapeutics News and Activities

Assertio Therapeutics is a company listed under the stock ticker ASRT (US).

Acquisition, funding and merger involving Assertio Therapeutics.

• Zydus Group has announced the acquisition of Assertio Therapeutics  (posted on May 19 2026).
• Garda Therapeutics has announced the acquisition of Assertio Therapeutics  (posted on May 8 2026).

View the org chart displaying its 21 main executives

Most searched biographies at Assertio Therapeutics

• Mark Reisenauer, Chief Executive Officer
• Sravan Emany, Director
• David Stark, Director

Popular executive movements at Assertio Therapeutics

• Paul Schwichtenberg, who was Executive Vice President, Chief Transformation Officer, is promoted to President and Chief Operating Officer  (posted on November 11 2025).
• Mark Reisenauer, who was Director, is promoted to Chief Executive Officer  (posted on October 28 2025).
• Brendan O'Grady, Chief Executive Officer and Director, has left the company  (posted on October 28 2025).

Create your alert
to follow the executive moves at Assertio Therapeutics.

Assertio Therapeutics has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Assertio Therapeutics

• Assertio to Be Acquired by Zydus Worldwide DMCC for $23.50 Per Share in Cash
• Assertio and Garda Mutually Agree to Delay Launch of Tender Offer
• Assertio and Garda Mutually Agree to Postpone Commencement of Tender Offer
• Assertio Announces Amended and Restated Merger Agreement with Garda Therapeutics
• Assertio and Garda Mutually Agree to Extend Tender Offer Deadline
• Assertio Provides Update on Garda Therapeutics Tender Process
• Assertio Announces Agreement to be Acquired by Garda Therapeutics
• Assertio Reports Fourth Quarter and Full Year 2025 Financial Results
• Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026
• Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements
• View more press releases Close

Social media about Assertio Therapeutics

• Assertio Therapeutics on Wikipedia, Google News & Yahoo Finance
• Assertio Therapeutics on LinkedIn, X (Twitter) & YouTube